BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 15944007)

  • 1. Galanin (2-11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes.
    Lu X; Lundström L; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):165-7. PubMed ID: 15944007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity.
    Lu X; Mazarati A; Sanna P; Shinmei S; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):147-52. PubMed ID: 15944003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes.
    Wang S; Hashemi T; Fried S; Clemmons AL; Hawes BE
    Biochemistry; 1998 May; 37(19):6711-7. PubMed ID: 9578554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and expression of the human galanin receptor GalR2.
    Bloomquist BT; Beauchamp MR; Zhelnin L; Brown SE; Gore-Willse AR; Gregor P; Cornfield LJ
    Biochem Biophys Res Commun; 1998 Feb; 243(2):474-9. PubMed ID: 9480833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining receptor-ligand interaction of human galanin receptor type 3.
    Runesson J; Sollenberg UE; Jurkowski W; Yazdi S; Eriksson EE; Elofsson A; Langel U
    Neurochem Int; 2010 Dec; 57(7):804-11. PubMed ID: 20817064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that the modulatory effect of galanin on inflammatory edema formation is mediated by the galanin receptor 3 in the murine microvasculature.
    Schmidhuber SM; Rauch I; Kofler B; Brain SD
    J Mol Neurosci; 2009 Feb; 37(2):177-81. PubMed ID: 18679831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3',5'-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin receptor 1 knockout mice.
    Badie-Mahdavi H; Lu X; Behrens MM; Bartfai T
    Neuroscience; 2005; 133(2):591-604. PubMed ID: 15885916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of the ligand binding site of the human galanin receptor type 2, identifying subtype selective interactions.
    Lundström L; Sollenberg UE; Bartfai T; Langel U
    J Neurochem; 2007 Dec; 103(5):1774-84. PubMed ID: 17953676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel GalR2-specific peptide agonist.
    Runesson J; Saar I; Lundström L; Järv J; Langel U
    Neuropeptides; 2009 Jun; 43(3):187-92. PubMed ID: 19467704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression of galanin and galanin receptors in olfactory ensheathing cells and effects of galanin on cells proliferation].
    Xia CY; Qi YT; Zhang Y; Yuan CG
    Shi Yan Sheng Wu Xue Bao; 2005 Apr; 38(2):98-104. PubMed ID: 16011241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled galanin receptor distribution in the rat central nervous system.
    Barreda-Gómez G; Giralt MT; Rodríguez-Puertas R
    Neuropeptides; 2005 Jun; 39(3):153-6. PubMed ID: 15944004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive and ligand-induced internalization of EGFP-tagged galanin R2 and Rl receptors in PC12 cells.
    Xia S; Kjaer S; Zheng K; Hu PS; Xu T; Hökfelt T; Xu ZQ
    Neuropeptides; 2005 Jun; 39(3):173-8. PubMed ID: 15885774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and functional characterization of galanin-like peptide fragments as potent galanin receptor agonists.
    Lang R; Berger A; Santic R; Geisberger R; Hermann A; Herzog H; Kofler B
    Neuropeptides; 2005 Jun; 39(3):179-84. PubMed ID: 15944009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galanin receptor subtypes.
    Wang S; Gustafson EL
    Drug News Perspect; 1998 Oct; 11(8):458-68. PubMed ID: 15616674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of galanin receptors 1 and 2 in the modulation of mouse vagal afferent mechanosensitivity.
    Page AJ; Slattery JA; Brierley SM; Jacoby AS; Blackshaw LA
    J Physiol; 2007 Sep; 583(Pt 2):675-84. PubMed ID: 17627995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of limbic status epilepticus by hippocampal galanin type 1 and type 2 receptors.
    Mazarati A; Lu X
    Neuropeptides; 2005 Jun; 39(3):277-80. PubMed ID: 15944022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Important pharmacophores for binding to galanin receptor 2.
    Lundström L; Lu X; Langel U; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):169-71. PubMed ID: 15944008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of galanin on proliferation and apoptosis of immature rat thymocytes.
    Trejter M; Brelinska R; Warchol JB; Butowska W; Neri G; Rebuffat P; Gottardo L; Malendowicz LK
    Int J Mol Med; 2002 Aug; 10(2):183-6. PubMed ID: 12119556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain.
    Hawes JJ; Picciotto MR
    J Comp Neurol; 2004 Nov; 479(4):410-23. PubMed ID: 15514977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and biochemical characterization of a recombinant human galanin GALR1 receptor: agonist character of chimeric galanin peptides.
    Fitzgerald LW; Patterson JP; Conklin DS; Horlick R; Largent BL
    J Pharmacol Exp Ther; 1998 Nov; 287(2):448-56. PubMed ID: 9808667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.